TIZANIDINE HCL CAS:64461-82-1
Tizanidine hydrochloride is widely utilized in the treatment of muscle spasticity, especially in patients with neurological disorders like multiple sclerosis, amyotrophic lateral sclerosis (ALS), or following spinal cord injuries. By selectively targeting α2-adrenergic receptors in the central nervous system, tizanidine reduces excessive motor neuron activity, thereby decreasing muscle tone and spasms. This action provides symptomatic relief, enabling patients to perform daily activities with greater ease and comfort. In addition to its use in managing muscle spasticity, tizanidine has been studied for its potential benefits in treating other conditions characterized by muscle tension or pain. For instance, it may be prescribed off-label for managing acute pain or chronic pain syndromes where muscle tightness contributes to discomfort. Its sedative properties can also be advantageous for patients experiencing anxiety related to muscle spasms or pain. Tizanidine is typically administered orally, and its dosage is tailored to individual patient needs, taking into consideration factors such as severity of spasticity, response to treatment, and potential side effects. The drug is preferred due to its relatively rapid onset of action and shorter half-life, which allows for more flexible dosing schedules compared to other muscle relaxants. Moreover, one of the significant advantages of tizanidine is its favorable safety profile when used correctly. While side effects can occur, including sedation, dry mouth, and hypotension, these are generally manageable and tend to diminish with continued use. This makes tizanidine a suitable option for long-term management of muscle spasticity in many patients. Furthermore, tizanidine's role in rehabilitation therapy cannot be overlooked. By effectively reducing spasticity, it assists in physical therapy sessions, allowing patients to engage more actively in therapeutic exercises aimed at improving strength, flexibility, and overall function. In conclusion, tizanidine hydrochloride serves as an essential therapeutic agent for managing muscle spasticity due to various neurological conditions. Its efficacy in relaxing muscles, combined with its safety profile, makes it a valuable tool in enhancing the quality of life for individuals suffering from debilitating muscle tightness and spasm-related discomfort. Ongoing research continues to explore its broader applications in pain management and rehabilitation therapies.
Composition | C9H9Cl2N5S |
Assay | 99% |
Appearance | white powder |
CAS No. | 64461-82-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |